These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 19001248

  • 1. Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures.
    Faught E, Holmes GL, Rosenfeld WE, Novak G, Neto W, Greenspan A, Schmitt J, Yuen E, Reines S, Haas M.
    Neurology; 2008 Nov 11; 71(20):1586-93. PubMed ID: 19001248
    [Abstract] [Full Text] [Related]

  • 2. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.
    Epilepsia; 2009 Mar 11; 50(3):398-405. PubMed ID: 18657175
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK, Mathew N, Diener HC, Hu P, Haas M, Novak GP, Study Group.
    Headache; 2009 Feb 11; 49(2):216-26. PubMed ID: 19222595
    [Abstract] [Full Text] [Related]

  • 4. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
    Halász P, Kälviäinen R, Mazurkiewicz-Beldzińska M, Rosenow F, Doty P, Hebert D, Sullivan T, SP755 Study Group.
    Epilepsia; 2009 Mar 11; 50(3):443-53. PubMed ID: 19183227
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
    Elger C, Halász P, Maia J, Almeida L, Soares-da-Silva P, BIA-2093-301 Investigators Study Group.
    Epilepsia; 2009 Mar 11; 50(3):454-63. PubMed ID: 19243424
    [Abstract] [Full Text] [Related]

  • 6. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE, Nordli DR, Rating D, Yang H, Schiemann-Delgado J, Duncan B, Levetiracetam N01009 Study Group.
    Epilepsia; 2009 May 11; 50(5):1141-9. PubMed ID: 19243423
    [Abstract] [Full Text] [Related]

  • 7. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ, Duncan R, Vespignani H, Solyom A, Bitenskyy V, Lucas C.
    Epilepsia; 2005 Jan 11; 46(1):31-41. PubMed ID: 15660766
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG, Berkovic SF, Black AB, Danta G, Hiersemenzel R, Schapel GJ, Vajda FJ.
    Epilepsy Res; 2005 Jan 11; 63(1):1-9. PubMed ID: 15716083
    [Abstract] [Full Text] [Related]

  • 13. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial.
    Chung S, Sperling MR, Biton V, Krauss G, Hebert D, Rudd GD, Doty P, SP754 Study Group.
    Epilepsia; 2010 Jun 11; 51(6):958-67. PubMed ID: 20132285
    [Abstract] [Full Text] [Related]

  • 14. Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials.
    Sperling MR, Greenspan A, Cramer JA, Kwan P, Kälviäinen R, Halford JJ, Schmitt J, Yuen E, Cook T, Haas M, Novak G.
    Epilepsia; 2010 Mar 11; 51(3):333-43. PubMed ID: 19863578
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
    French JA, Krauss GL, Steinhoff BJ, Squillacote D, Yang H, Kumar D, Laurenza A.
    Epilepsia; 2013 Jan 11; 54(1):117-25. PubMed ID: 22905857
    [Abstract] [Full Text] [Related]

  • 17. A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures.
    Elger CE, Stefan H, Mann A, Narurkar M, Sun Y, Perdomo C.
    Epilepsy Res; 2010 Feb 11; 88(2-3):255-63. PubMed ID: 20061123
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.
    Brodie MJ, Lerche H, Gil-Nagel A, Elger C, Hall S, Shin P, Nohria V, Mansbach H, RESTORE 2 Study Group.
    Neurology; 2010 Nov 16; 75(20):1817-24. PubMed ID: 20944074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.